Researchers say how quickly a person’s pupil dilates while taking cognitive tests
Alzheimer’s disease (AD) begins to alter and damage the brain years — even decades — before symptoms appear, making early identification of AD risk paramount to slowing its progression.
In a new study published online in the September 9, 2019 issue of the Neurobiology of Aging, scientists at University of California San Diego School of Medicine say that, with further developments, measuring how quickly a person’s pupil dilates while they are taking cognitive tests may be a low-cost, low-invasive method to aid in screening individuals at increased genetic risk for AD before cognitive decline begins.
In recent years, researchers investigating the pathology of AD have primarily directed their attention at two causative or contributory factors: the accumulation of protein plaques in the brain called amyloid-beta and tangles of a protein called tau. Both have been linked to damaging and killing neurons, resulting in progressive cognitive dysfunction.
The new study focuses on pupillary responses which are driven by the locus coeruleus (LC), a cluster of neurons in the brainstem involved in regulating arousal and also modulating cognitive function. Tau is the earliest occurring known biomarker for AD; it first appears in the LC; and it is more strongly associated with cognition than amyloid-beta. The study was led by first author William S. Kremen, PhD, and senior author Carol E. Franz, PhD, both professors of psychiatry and co-directors of the Center for Behavior Genetics of Aging at UC San Diego School of Medicine.
The LC drives pupillary response — the changing diameter of the eyes’ pupils — during cognitive tasks. (Pupils get bigger the more difficult the brain task.) In previously published work, the researchers had reported that adults with mild cognitive impairment, often a precursor to AD, displayed greater pupil dilation and cognitive effort than cognitively normal individuals, even if both groups produced equivalent results. Critically, in the latest paper, the scientists link pupillary dilation responses with identified AD risk genes.
“Given the evidence linking pupillary responses, LC and tau and the association between pupillary response and AD polygenic risk scores (an aggregate accounting of factors to determine an individual’s inherited AD risk), these results are proof-of-concept that measuring pupillary response during cognitive tasks could be another screening tool to detect Alzheimer’s before symptom appear,” said Kremen.
Learn more: How the Eyes Might Be Windows to the Risk of Alzheimer’s Disease
The Latest on: Diagnosing Alzheimer’s
[google_news title=”” keyword=”diagnosing Alzheimers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Diagnosing Alzheimer’s
- Record number of people are receiving a dementia diagnosis in Englandon July 22, 2024 at 8:18 am
New figures from the NHS show that record numbers of people are being diagnosed with dementia in England. The latest data shows that a record 487,432 people in England had a diagnosis as of June 2024.
- Study identifies new biomarkers of Alzheimer's diseaseon July 22, 2024 at 6:50 am
Recent advances in the study of proteomes (i.e., the entire range of proteins expressed by human cells and tissues) have opened new opportunities for identifying the biological markers of specific ...
- Cassava Alzheimer’s drug set for first Phase 3 readout by December 2024on July 22, 2024 at 6:09 am
Cassava Sciences (NASDAQ:SAVA) executive chairman and principal executive officer Rick Barry said on Monday that the company’s first Phase 3 trial of its lead drug candidate, simufilam, is expected to ...
- Chef creates book after fearing mum's Alzheimer's diagnosis would see recipes loston July 22, 2024 at 6:08 am
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
- New Alzheimer's Mimic Identifiedon July 19, 2024 at 12:24 pm
Unlike Alzheimer's, LANS symptoms are restricted to memory loss and don't involve other cognitive domains. A new memory-loss syndrome that mimics the clinical features of Alzheimer's disease was ...
- Scientists create AI tool that helps predict Alzheimer's with up to 82% accuracyon July 19, 2024 at 7:18 am
Scientists have developed an artificially-intelligent tool that can accurately predict whether people with early signs of dementia will develop Alzheimer’s disease.
- Mayo Clinic finds new type of memory loss that’s often mistaken for Alzheimer’son July 18, 2024 at 4:20 pm
the Mayo Clinic Study of Aging and the Alzheimer's Disease Neuroimaging Initiative to create a set of criteria that can be used to diagnose LANS. David T. Jones, M.D., a Mayo Clinic neurologist and ...
- Executives Depart Cassava, Maker of Disputed Alzheimer’s Drugon July 18, 2024 at 3:21 pm
The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.
- New drug gives hope to South Floridians affected by Alzheimer’son July 18, 2024 at 3:00 am
READ MORE: Report: Alzheimer's and dementia caregivers total 840K in Florida, bear heavy burden The new drug is bringing hope to hundreds of thousands of Floridians who have the disease or have loved ...
- Alzheimer’s app could be key for newly diagnosed patients: ‘Meets an important need’on July 10, 2024 at 2:10 pm
highwaystarz - stock.adobe.com Personalized prognoses for people diagnosed with Alzheimer’s disease soon may only be a click away. Researchers at Amsterdam University Medical Center say they ...
via Bing News